Actelion shares plunge on report it eyes 'complicated' J&J deal

ZURICH (Reuters) - Shares in Swiss biotech company Actelion plunged on Tuesday after a report the company was not actively considering selling itself, but instead weighing a "complicated deal" to...

from Reuters: Deals http://ift.tt/2g0zOSD
via IFTTT